It's Been Quite Tough: Gurmeet Choudhry Has Not Eaten Roti and Rice For More Than A Year; How Does It Affect Your Health? Mediterranean Diet Ranked the Best for 8th Year In a Row; Here's How It ...

Although progression-free survival and overall survival data are not yet available from BREAKWATER, the FDA said that these outcomes will provide the post-marketing confirmatory evidence needed to ...

Lupin's shares saw a 2. Shares of Lupin will remain in focus on Thursday after the drugmaker received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application ...

Drug firm Lupin Ltd on Wednesday (December 18) announced that it has received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for HIV tablets ...

History is made as the FDA approves Mesoblast’s Ryoncil for paediatric graft-versus-host disease LTR ... About 50% of men stop taking the oral tablets within a year, because of the timing problem and ...

ISLAMABAD: Based on a few datasets, the government claimed the effectiveness of its policies towards macroeconomic stability on Wednesday and approved about Rs 44 billion in supplementary grants ...

The Food and Drug Administration (FDA) announced in a statement Tuesday that it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...

This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease. The Food and Drug Administration (FDA) approved Ryoncil (remestemcel-L-rknd ...

The FDA has granted ensartinib approval for adult patients with ALK-positive non–small cell lung cancer. Ensartinib has received FDA approval for the first-line treatment of anaplastic lymphoma kinase ...

The US Food and Drug Administration (FDA) has approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for the treatment of adults with ALK-positive locally advanced or metastatic non-small cell ...

Granules has received approval in the first review cycle, reflecting the company's consistent focus on regulatory excellence and expedited product delivery. Lisdexamfetamine Dimesylate Chewable ...